Publications scientifiques sur le lymphome - Experts Recherche Lymphome

Lysa 2021_LYSA_Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumor volume prediction using a convolutional neural network

Paul Blanc-Durand, Simon Jégou, Salim Kanoun, Alina Berriolo-Riedinger, Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Thomas Carlier, Steven Le Gouill, René-Olivier Casasnovas, Michel Meignan, Emmanuel Itti

Eur J Nucl Med Mol Imaging . 2021 May;48(5):1362-1370. doi: 10.1007/s00259-020-05080-7. En savoir plus

Lysa 2021_LYSA_Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA

Steven Le Gouill, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Hervé Maisonneuve, Rémy Gressin, Krimo Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc Fornecker, Réda Bouabdallah, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Loic Chartier, Philippe Ruminy, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Alina Berriolo-Riedinger, Josette Brière, Jean-Philippe Jais, Thierry Jo Molina, Emmanuel Itti, René-Olivier Casasnovas.

Blood . 2021 Apr 29;137(17):2307-2320. doi: 10.1182/blood.2020008750. En savoir plus

Lysa 2021_LYSA_Lenalidomide tiggers T-cell effector functions in vivo in patients with follicular lymphoma

Cédric Ménard, Delphine Rossille, Joelle Dulong, Tien-Tuan Nguyen, Ilenia Papa, Maelle Latour, Nadège Bescher, Isabelle Bezier, Myriam Chouteau, Thierry Fest, Roch Houot, Franck Morshhauser, Karin Tarte

Blood Adv . 2021 Apr 27;5(8):2063-2074. doi: 10.1182/bloodadvances.2020003774. En savoir plus

Lysa 2021_LYSA_Sub-Cutaneous Rituximab-MiniCHOP compared to Sub-Cutaneous Rituximab-MiniCHOP plus Lenalidomide in Diffuse Large B Cell Lymphoma for Patients of 80 Years or older.

Lucie Oberic, Mathieu Puyade, Frederic Peyrade, Hervé Maisonneuve, Julie Abraham, Pierre Feugier, Catherine Thieblemont, Gilles Salles, Fontanet Bijou, Gian-Matteo Pica, Philippe Ruminy, Peggy Dartigues-Cuillères, Gandhi Damaj, Philippe Gaulard, Jean-François Emile, Bettina Fabiani, Hervé Tilly, Corinne Haioun and Fabrice Jardin

J Clin Oncol . 2021 Apr 10;39(11):1203-1213. doi: 10.1200/JCO.20.02666. En savoir plus

Lysa 2021_LYSA_A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort

Hervé Ghesquières, Cédric Rossi, Fanny Cherblanc, Sandra Le Guyader-Peyrou, Fontanet Bijou, Pierre Sujobert, Pascale Fabbro-Peray, Adeline Bernier, Aurélien Belot, Loic Chartier, Luc-Matthieu Fornecker, Isabelle Baldi, Krimo Bouabdallah, Camille Laurent, Lucie Oberic, Nadine Morineau, Steven Le Gouill, Franck Morschhauser, Corinne Haioun, Gandhi Damaj, Stéphanie Guidez, Gaëlle Labouré, Olivier Fitoussi, Laure Lebras, Rémy Gressin, GIlles Salles, Loïc Ysabaert, Alain Monnereau

BMC Public Health . 2021 Mar 2;21(1):432. doi: 10.1186/s12889-021-10433-4. En savoir plus

Lysa 2021_LYSA_Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides linger disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from LyMA prospective trial

Benoit Tessoulin, David Chiron, Catherine Thieblemont, Lucie Oberic, Kamal Bouadballah, Emmanuel Gyan, Gandhi Damaj, Vincent Ribrag, Rémy Gressin, Pierre Feugier, Olivier Casasnovas, Hacène Zerazhi, François Lemonnier, Hervé Maisonneuve, Clementine Joubert, Eric Van Den Neste, Thierry Lamy, Hervé TIlly, Anne Moreau, Olivier Hermine, Steven Le Gouill

Bone Marrow Transplant . 2021 Mar 3. doi: 10.1038/s41409-020-01198-2. En savoir plus

Lysa 2021_LYSA_Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lyphoma: a phase 1/2 trial

Steven Le Gouill, Franck Morschhauser, David Chiron, Krimo Bouabdallah, Guillaume Cartron, Olivier Casasnovas, Caroline Bodet-Milin, Sylviane Ragot, Céline Bossard, Nathalie Nadal, Charles Herbaux, Benoit Tessoulin, Emmannuelle Tchernonog, Cédric Rossi, Rory McCulloch, Thomas Gastinne, Mary B Callanan, Simon Rule

Blood . 2021 Feb 18;137(7):877-887. doi: 10.1182/blood.2020008727. En savoir plus

Lysa 2021_LYSA_BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres

Hervé Ghesquières, Cécile Dalban, Emmanuelle Nicolas-Virelizier, Fabrice Jardin, Fabien Le Bras, Steven Le Gouill, Olivier Casasnovas, Séraphine Vizoso, Caroline Hernandez, Séverine Metzger, David Pérol, Guillaume Cartron

Br J Haematol . 2021 Feb;192(3):e94-e98. doi: 10.1111/bjh.17279. En savoir plus

Lysa 2021_LYSA_Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma

François Lemonnier, Violaine Safar, Asma Beldi-Ferchiou, Anne-Ségolène Cottereau, Emmanuel Bachy, Guillaume Cartron, Virginie Fataccioli, Laura Pelletier, Cyrielle Robe, Audrey Letourneau, Edoardo Missiaglia, Slim Fourati, Marie-Pierre Moles-Moreau, Alain Delmer, Reda Bouabdallah, Laurent Voillat, Stéphanie Becker, Céline Bossard, Marie Parrens, Olivier Casasnovas, Victoria Cacheux, Caroline Régny, Vincent Camus, Marie-Hélène Delfau-Larue, Michel Meignan, Laurence de Leval, Philippe Gaulard, Corinne Haioun

Blood Adv . 2021 Jan 26;5(2):539-548. doi: 10.1182/bloodadvances.2020003081. En savoir plus

Lysa 2021_LYSA_Alemtuzumab plus CHOP versus CHOPin elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

Wulf GG, Altmann B, Ziepert M, D'Amore F, Held G, Greil R, Tournilhac O, Relander T, Viardot A, Wilhelm M, Wilhelm C, Pezzutto A, Zijlstra JM, Neste EVD, Lugtenburg PJ, Doorduijn JK, Gelder MV, van Imhoff GW, Zettl F, Braulke F, Nickelsen M, Glass B, Rosenwald A, Gaulard P, Loeffler M, Pfreundschuh M, Schmitz N, Trümper L;

Leukemia . 2021 Jan;35(1):143-155. doi: 10.1038/s41375-020-0838-5 En savoir plus

Lysa 2020_LYSA_Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group

Yannick Le Bris, Florence Magrangeas, Anne Moreau, David Chiron, Catherine Guérin-Charbonnel, Olivier Theisen, Olivier Pichon, Danielle Canioni, Barbara Burroni, Hervé Maisonneuve, Catherine Thieblemont, Lucie Oberic, Emmanuel Gyan, Catherine Pellat-Deceunynck, Olivier Hermine, Marie-Hélène Delfau-Larue, Benoît Tessoulin, Marie-Christine Béné, Stéphane Minvielle, Steven Le Gouill

Hematol Oncol . 2020 Oct;38(4):446-455. doi: 10.1002/hon.2750. En savoir plus

Lysa 2020_LYSA_Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T 3 phase IB trial of the LYSA

Benoît Tessoulin, Kamal Bouabdallah, Barbara Burroni, Thierry Lamy, Remy Gressin, Guillaume Cartron, Catherine Thieblemont, Clémentine Sarkozy, Corinne Haioun, Olivier Casasnovas, Clementine Joubert, Emmanuel Gyan, Olivier Hermine, Steven Le Gouill

Ann Hematol . 2020 Aug;99(8):1771-1778. doi: 10.1007/s00277-020-04159-3. En savoir plus